Timothy M. McManus - 30 Jan 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
30 Jan 2023
Net transactions value
-$2,007,067
Form type
4
Filing time
01 Feb 2023, 19:02:22 UTC
Previous filing
11 Jan 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale $1,981,607 -7,800 -36% $254.05 14,087 30 Jan 2023 Direct F1
transaction HCA Common Stock Sale $25,460 -100 -0.71% $254.60 13,987 30 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +17,051 $0.000000 17,051 30 Jan 2023 Common Stock 17,051 $253.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.54 to $254.475, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.